Clinical Trial Update: Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates that a Phase 1/Phase 2 study evaluating human umbilical cord mesenchymal stem cells (iSCLife-MDS) for myelodysplastic syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• iSCLife-MDS

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: SUSPENDED